Organogenesis (ORGO) director adds 10,000 shares in open-market purchase
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Organogenesis Holdings Inc. director Michael Joseph Driscoll bought 10,000 shares of Class A Common Stock in an open-market purchase. He paid about $2.67 per share, for a total of roughly $26,688. Following this transaction, he directly owns 225,707 shares, making this a relatively small addition to his stake.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares ($26,688)
Net Buy
1 txn
Insider
Driscoll Michael Joseph
Role
Director
Bought
10,000 shs ($27K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock | 10,000 | $2.6688 | $27K |
Holdings After Transaction:
Class A Common Stock — 225,707 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did ORGO director Michael Driscoll report?
Michael Joseph Driscoll reported an open-market purchase of 10,000 Class A Common shares of Organogenesis Holdings Inc. He bought the shares on March 9, 2026, increasing his direct ownership position in the company.
At what price did Michael Driscoll buy ORGO stock on March 9, 2026?
He bought the shares at an average price of about $2.6688 per share. This implies a total purchase value of roughly $26,688, based on the reported transaction price and share count.
Is Michael Driscoll’s March 2026 ORGO trade a purchase or sale?
The March 9, 2026 Form 4 shows a purchase of Organogenesis stock. The transaction is coded “P,” indicating an open-market or private purchase rather than a sale or other type of disposition.
Does the March 2026 ORGO Form 4 involve derivative securities or options?
The reported transaction involves only non-derivative Class A Common Stock. The derivative securities section in the filing shows no entries, indicating no option exercises or other derivative transactions in this specific Form 4.
What does Michael Driscoll’s ORGO Form 4 mean for insider activity levels?
This Form 4 reflects a single open-market purchase of 10,000 shares, categorized as a net-buy. The filing shows no sales, option exercises, gifts, or restructuring transactions for this date, indicating straightforward buying activity.